Canada Tenders Offer for New Smallpox Vaccine

Canada has asked vaccine makers for proposals to supply a new type of smallpox vaccine for 10,000 people, with an option to a second batch for 10,000 more, Danish pharmaceutical firm Bavarian Nordic announced yesterday (see GSN, Nov. 14, 2005).

The modified vaccinia Ankara-based vaccine is designed to reduce complications caused by the existing smallpox vaccine, according to Bavarian Nordic (see GSN, April 9).

The Canadian decision to pursue a new vaccine indicates that the MVA-based vaccine is gaining acceptance, said a company release (Bavarian Nordic release, April 10).

Back to top
About Newswire  |  Contact National Journal  |  Re-Use Guidelines © Copyright 2008 by National Journal Group, Inc. The material in this section is produced independently for NTI by National Journal Group, Inc. Any reproduction or retransmission, in whole or in part, is a violation of federal law and is strictly prohibited without the consent of the National Journal Group, Inc. All rights reserved.